Andrew Bellinger

Chief Scientific Officer, Verve Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 14, 2022Exercised options 36,000 shares at $2.87 of Verve Therapeutics, Inc.²
Dec 1, 2022Sold 865 shares at $22.95 of Verve Therapeutics, Inc.³
Oct 28, 2022Sold 10,000 shares at $39.90 of Verve Therapeutics, Inc.⁴
Oct 28, 2022Exercised options 10,000 shares at $1.48 of Verve Therapeutics, Inc.⁴
Sep 23, 2022Sold 3,202 shares at $36.03 of Verve Therapeutics, Inc.⁵
Sep 23, 2022Sold 36,798 shares at $35.31 of Verve Therapeutics, Inc.⁵
Sep 23, 2022Exercised options 40,000 shares at $1.48 of Verve Therapeutics, Inc.⁵
Sep 23, 2022Sold 13,368 shares at $35.59 of Verve Therapeutics, Inc.⁵
Sep 23, 2022Sold 6,632 shares at $34.67 of Verve Therapeutics, Inc.⁵
Sep 23, 2022Exercised options 20,000 shares at $1.48 of Verve Therapeutics, Inc.⁵
Jul 20, 2022Sold 20,000 shares at $34.90 of Verve Therapeutics, Inc.⁶
Jul 20, 2022Exercised options 20,000 shares at $1.39 of Verve Therapeutics, Inc.⁶
Jul 13, 2022Sold 10,000 shares at $24.90 of Verve Therapeutics, Inc.⁷
Jul 13, 2022Exercised options 10,000 shares at $1.48 of Verve Therapeutics, Inc.⁷
Dec 22, 2021Sold 4,871 shares at $39.37 of Verve Therapeutics, Inc.⁸
Dec 22, 2021Sold 8,161 shares at $38.60 of Verve Therapeutics, Inc.⁸
Dec 22, 2021Sold 1,968 shares at $37.42 of Verve Therapeutics, Inc.⁸
Dec 22, 2021Exercised options 15,000 shares at $1.48 of Verve Therapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.